AAAAAA
Results:
1-19
|
Results: 19
Authors:
Hietala, J
Kuoppamaki, M
Majasuo, H
Palvimaki, EP
Laakso, A
Syvalahti, E
Citation: J. Hietala et al., Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist butnot antagonist binding to 5-HT2c receptors after chronic treatment, PSYCHOPHAR, 157(2), 2001, pp. 180-187
Authors:
Penttila, J
Syvalahti, E
Hinkka, S
Kuusela, T
Scheinin, H
Citation: J. Penttila et al., The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system - A randomised placebo-controlled study on healthy volunteers, PSYCHOPHAR, 154(4), 2001, pp. 343-349
Authors:
Laakso, A
Bergman, J
Haaparanta, M
Vilkman, H
Solin, O
Syvalahti, E
Hietala, J
Citation: A. Laakso et al., Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia, SCHIZOPHR R, 52(1-2), 2001, pp. 115-120
Authors:
Laakso, MP
Tiihonen, J
Syvalahti, E
Vilkman, H
Laakso, A
Alakare, B
Rakkolainen, V
Salokangas, RKR
Koivisto, E
Hietala, J
Citation: Mp. Laakso et al., A morphometric MRI study of the hippocampus in first-episode, neuroleptic-naive schizophrenia, SCHIZOPHR R, 50(1-2), 2001, pp. 3-7
Authors:
Hale, A
Azorin, JM
Kasper, S
Maier, W
Syvalahti, E
Van der Burght, M
Sloth-Nielsen, M
Wehnert, A
Citation: A. Hale et al., Sertindole is associated with a low level of extrapyramidal symptoms in schizophrenic patients: Results of a phase III trial, INT J PSYC, 4(1), 2000, pp. 47-54
Authors:
Hale, A
Azorin, JM
Kasper, S
Maier, W
Syvalahti, E
Van der Burght, M
Sloth-Nielsen, M
Wehnert, A
Citation: A. Hale et al., Sertindole improves both the positive and negative symptoms of schizophrenia: Results of a phase III trial, INT J PSYC, 4(1), 2000, pp. 55-62
Authors:
Lehtinen, V
Aaltonen, J
Koffert, T
Rakkolainen, V
Syvalahti, E
Citation: V. Lehtinen et al., Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed?, EUR PSYCHIA, 15(5), 2000, pp. 312-320
Authors:
Taiminen, T
Salokangas, RKR
Saarijarvi, S
Syvalahti, E
Niemi, H
Ahola, V
Lehto, H
Citation: T. Taiminen et al., Symptom dimensions, social network, and caregiver burden in chronic schizophrenia, NORD J PSY, 54(2), 2000, pp. 121-125
Authors:
Rasanen, S
Pakaslahti, A
Syvalahti, E
Jones, PB
Isohanni, M
Citation: S. Rasanen et al., Sex differences in schizophrenia: A review, NORD J PSY, 54(1), 2000, pp. 37-45
Authors:
Vilkman, H
Kajander, J
Nagren, K
Oikonen, V
Syvalahti, E
Hietala, J
Citation: H. Vilkman et al., Measurement of extrastriatal D-2-like receptor binding with [C-11]FLB 457 - a test-retest analysis, EUR J NUCL, 27(11), 2000, pp. 1666-1673
Authors:
Hallikainen, T
Lachman, H
Saito, T
Volavka, J
Kauhanen, J
Salonen, JT
Ryynanen, OP
Koulu, M
Karvonen, MK
Pohjalainen, T
Syvalahti, E
Hietala, J
Tiihonen, J
Citation: T. Hallikainen et al., Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior, AM J MED G, 96(3), 2000, pp. 348-352
Authors:
Salokangas, RKR
Vilkman, H
Ilonen, T
Taiminen, T
Bergman, J
Haaparanta, M
Solin, O
Alanen, A
Syvalahti, E
Hietala, J
Citation: Rkr. Salokangas et al., High levels of dopamine activity in the basal ganglia of cigarette smokers, AM J PSYCHI, 157(4), 2000, pp. 632-634
Authors:
Laakso, A
Vilkman, H
Alakare, B
Haaparanta, M
Bergman, J
Solin, O
Peurasaari, J
Rakkolainen, V
Syvalahti, E
Hietala, J
Citation: A. Laakso et al., Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography, AM J PSYCHI, 157(2), 2000, pp. 269-271
Authors:
Kanerva, H
Vilkman, H
Nagren, K
Kilkku, O
Kuoppamaki, M
Syvalahti, E
Hietala, J
Citation: H. Kanerva et al., Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration - a positron emission tomography study, PSYCHOPHAR, 145(1), 1999, pp. 76-81
Authors:
Hallikainen, T
Saito, T
Lachman, HM
Volavka, J
Pohjalainen, T
Ryynanen, OP
Kauhanen, J
Syvalahti, E
Hietala, J
Tiihonen, J
Citation: T. Hallikainen et al., Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior, MOL PSYCHI, 4(4), 1999, pp. 385-388
Authors:
Tiihonen, J
Hallikainen, T
Lachman, H
Saito, T
Volavka, J
Kauhanen, J
Salonen, JT
Ryynanen, OP
Koulu, M
Karvonen, MK
Pohjalainen, T
Syvalahti, E
Hietala, J
Citation: J. Tiihonen et al., Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism, MOL PSYCHI, 4(3), 1999, pp. 286-289
Authors:
Hietala, J
Syvalahti, E
Vilkman, H
Vuorio, K
Rakkolainen, V
Bergman, J
Haaparanta, M
Solin, O
Kuoppamaki, M
Eronen, E
Ruotsalainen, U
Salokangas, RKR
Citation: J. Hietala et al., Depressive symptoms and presynaptic dopamine function in neuroleptic-naiveschizophrenia, SCHIZOPHR R, 35(1), 1999, pp. 41-50
Authors:
Hietala, J
Nagren, K
Lehikoinen, P
Ruotsalainen, U
Syvalahti, E
Citation: J. Hietala et al., Measurement of striatal D-2 dopamine receptor density and affinity with [C-11]-raclopride in vivo: A test-retest analysis, J CEREBR B, 19(2), 1999, pp. 210-217
Authors:
Saarijarvi, S
Taiminen, T
Syvalahti, E
Niemi, H
Ahola, V
Lehto, H
Salokangas, RKR
Citation: S. Saarijarvi et al., Relatives' participation in a clinical drug trial of schizophrenic outpatients improves their psychologic well-being, NORD J PSY, 52(5), 1998, pp. 389-393
Risultati:
1-19
|